アテレクトミー装置の世界市場 (Covid-19発生後の改訂版)：種類別・用途別・エンドユース別・地域別 - 市場分析、規模、シェア、動向、予測 (2020～2026年)
Atherectomy Devices Market (COVID-19 Updated), By Types, By Application, By End Use, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026
|アテレクトミー装置の世界市場 (Covid-19発生後の改訂版)：種類別・用途別・エンドユース別・地域別 - 市場分析、規模、シェア、動向、予測 (2020～2026年)|
発行: AnalystView Market Insights
ページ情報: 英文 182 Pages
当レポートでは、世界のアテレクトミー装置 (粥腫 (アテローム) 切除装置) の市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、種類別・用途別・エンドユース別・地域別の市場動向見通し (過去5年間・今後7年間分)、主要企業のプロファイルなどについて調査しております。
Atherectomy devices market was valued at USD 590.8 million by 2019, growing with 6.8% CAGR during the forecast period, 2020-2026
Atherectomy is a surgical technique that is used for widening the narrow arteries by the removal of additional plaque. This additional plaque is removed by using a flexible and elastic pipe that consists of a definite angle. This endovascular surgery is used to restore the blood flow to the affected tissues or organs of the patients with atherosclerosis. Moreover, the atherectomy devices are used for removing the plaque and thrombus from various contaminated pathways. These devices are useful in the actual and active treatment of both coronary and peripheral diseases. Atherectomy devices are specially designed for vaporizing, cutting, shaving, and sanding, of the plaques.
The rising geriatric population, growing prevalence of cardiovascular diseases, and increasing consumption of tobacco are some of the major factors driving the growth of the global atherectomy devices market. For example, as per the World Health Organization (WHO), cardiac problems are the number one cause of death (i.e. an estimated more than 18 million people died in 2017) worldwide compared to any other diseases. Moreover, the growing adoption of advanced procedures of atherectomy that includes minimally invasive techniques will further lift the demand for atherectomy devices during the forecast period. The industry players are launching new products and also adopting mergers & acquisition tactics to increase the market growth. For instance, Spectranetics was acquired by Koninklijke Philips N.V to strengthen and expand its image in the wordwide market. Philips made use of Spectranetics' existing services, software, and devices to make a strategic geographical expansion. On the flip side, postoperative complications associated with the atherectomy treatment and dearth of skilled medical professionals are anticipated to be major threats for industry growth.
Depending upon types, the wordwide industry is categorized into rotational, directional, laser, and orbital atherectomy. Of these, the directional category ruled the market in 2019 and is likey to grow at a rapid pace during the period of forecast. This growth is mainly attributed to its well-capability of plaque debulking and easy availability in different sizes. The demand for such device is also growing owing to its proven efficacy in clinical studies. Some of these trials are DEFINITIVE LE and EASE, which showed a success rate of more than 90% by guaranteeing the efficacy of the concerned products.
On contrary, the rotational products are projectedd to witness noteworthy growth in the projected timeframe. A huge percentage of cases do not require clinical assistance for up to several months after taking the treatment form rotational atherectomy products.
Neurovascular, cardiovascular, and peripheral vascular are the major applications in this study. Of which, the peripheral vascular segment is estimated to witness a profitable growth owing to the growing occurrence of peripheral vascular diseases because of changing lifestyles. The blockage of blood vessels is the main cause of peripheral vascular disease, and if left untreated it affects the kidney and results in stroke or aneurysm. Hence, the peripheral vascular atherectomy devices are becoming popular, especially among clinicians to promote minimal invasive and faster procedures that enhance business growth.
On the basis of end-users, the global industry is categorized into an ambulatory care center, hospitals & surgical centers, research laboratories & academic institutes, and others. The hospitals & surgical centers segment is anticipated to experience robust growth until the end of 2026. This growth is majorly due to the rising preference of patients towards the atherectomy surgery because they are suitable as compared to other invasive techniques. Additionally, the geriatric population who are the most affected to various critical diseases frequently prefer atherectomy surgery techniques in hospitals. The reason for this preference is because hospitals are well-established with all the necessary and advanced medical devices. This will likely help the hospitals & surgical centers segment to grow in the coming years. On the other side, ambulatory care facilities are projected to grow with promising growth rate during the study period.
Geographically, the global market for atherectomy devices is segmented into North America, Asia Pacific, Europe, Latin America, and MEA. The North America region is equipped with the highest number of approved medical devices and also has a suitable reimbursement scenario, which is expected to propel the growth of atherectomy devices in this region. In addition, a strong preference for minimally invasive surgical technique is observed in this region, which will increase the demand for atherectomy devices for vascular surgeries.
On the other hand, the Asia Pacific market is projected to witness the fastest growth during the forecast period. An unhealthy diet, smoking, socioeconomic changes, heavy consumption of alcohol, and the growing elderly population are some of the factors influencing the growth of atherectomy devices in this region.
Key Vendors Takeaway
Some of the key players in the global atherectomy devices market include Cardiovascular Systems Inc., Boston Scientific Corporation, Medtronic (Covidien), VOLCANO CORPORATION, Spectranetics, Avinger Inc., Straub Medical AG, Koninklijke Philips N.V, ST. JUDE MEDICAL, Terumo IS, Cardinal Health (Cordis), and BARD Peripheral Vascular. These players are adopting various strategies such as joint ventures, acquisitions, new product development, and mergers to strengthen their company position in the market.
For instance, Avinger introduced a new product namely, "Pantheris", which is a new imaging technology that integrates OCT (Ocular Coherence Tomography). In December 2015, Covidien was acquired by Medtronic to geographically expand their business, which ultimately helped the atherectomy devices market to grow exponentially.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year - 2015 to 2018
Base Year - 2019
Estimated Year - 2020
Projected Year - 2026
Traders, Distributors, and Suppliers
Government and Regional Agencies
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
Cardiovascular Systems Inc.
Boston Scientific Corporation
Straub Medical AG
Koninklijke Philips N.V
Cardinal Health (Cordis)
BARD Peripheral Vascular.
MARKET, BY TYPES
MARKET, BY APPLICATION
Peripheral Vascular Applications
MARKET, BY END USE
Ambulatory Care Centers
Hospitals & Surgical Centers
MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East and Africa
United Arab Emirates
Rest of MEA